Adverse reactions during treatment of Parkinson's disease with levodopa.
D000328:Adult; D000368:Aged; D003298:Coombs Test; D003863:Depression / Q000139:chemically induced; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects*; D004381:Duodenal Ulcer / Q000139:chemically induced; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000139:chemically induced; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine